Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2024 Oct 15;16(10):1615. doi: 10.3390/v16101615

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2024 by the authors.

Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

Circulating concentrations of inflammatory and endothelial markers at presentation in patients with COVID-19 by severity outcome at D7: GeoSentinel (2020–2021). Circulating concentrations of inflammatory and endothelial markers at inclusion including (A) IL-6, (B) VWF-a2, (C) C5a, (D) IL-1Ra, (E) Il-8, (F) sTREM-1, and (G) suPAR stratified by severity outcome at D7. Discharged at D7 (n = 79), hospitalized on ward at D7 (n = 76), and death or ICU (n = 24) includes those who were admitted to the ICU (n = 20) and those who died by D7 (n = 4). Concentrations of C5a (C) have been logged for visualization. Significant p-values (p < 0.05 by Kruskal–Wallis) are in bold. Abbreviations: complement component C5a (C5a), interleukin-1 receptor antagonist (IL-1Ra), interleukin-6 (IL-6), interleukin-8 (IL-8), soluble tumor necrosis factor receptor-1 (sTREM-1), soluble urokinase-type plasminogen activator receptor (suPAR), von Willebrand factor (VWF-a2).